Physical comorbidities in men with mood and anxiety disorders: a population-based study

BMC Medicine

Lana J Williams²  Sharon L Brennan³  Paolo Girardi¹  Michael Berk⁴  Mark A Kotowicz⁵  Julie A Pasco⁵  Amanda L Stuart³  Livia Sanna¹ 

[1] Unit of Psychiatry, Neurosciences, Mental Health and Sensory Organs Department (NeSMOS), Faculty of Medicine and Psychology, Sant’Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1035–1037 00189, Rome, Italy;Department of Psychiatry, The University of Melbourne, Parkville 3010, Australia;School of Medicine, Deakin University: The Geelong Hospital, PO Box 281, Geelong 3220, Australia;Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville 3010, Australia;NorthWest Academic Centre, Department of Medicine, The University of Melbourne, Western Health, 176 Furlong Road, St Albans 3021, Australia

关键词: Physical illness;    Population-based study;    Medical burden;    Comorbidity;    Anxiety disorder;    Mood disorder;   

Others  :  857085
DOI  :  10.1186/1741-7015-11-110

 received in 2012-07-13, accepted in 2013-04-04,  发布年份 2013

【 摘 要 】

Background

The mind-body nexus has been a topic of growing interest. Further data are however required to understand the specific relationship between mood and anxiety disorders and individual physical health conditions, and to verify whether these psychiatric disorders are linked to overall medical burden.

Methods

This study examined data collected from 942 men, 20 to 97 years old, participating in the Geelong Osteoporosis Study. A lifetime history of mood and anxiety disorders was identified using the Structured Clinical Interview for DSM-IV-TR Research Version, Non-patient edition (SCID-I/NP). The presence of medical conditions (lifetime) was self-reported and confirmed by medical records, medication use or clinical data. Anthropometric measurements and socioeconomic status (SES) were determined and information on medication use and lifestyle was obtained via questionnaire. Logistic regression models were used to test the associations.

Results

After adjustment for age, socioeconomic status, and health risk factors (body mass index, physical activity and smoking), mood disorders were associated with gastro oesophageal reflux disease (GORD), recurrent headaches, blackouts and/or epilepsy, liver disorders and pulmonary disease in older people, whilst anxiety disorders were significantly associated with thyroid, GORD and other gastrointestinal disorders, and psoriasis. Increased odds of high medical burden were associated with both mood and anxiety disorders.

Conclusions

Our study provides further population-based evidence supporting the link between mental and physical illness in men. Understanding these associations is not only necessary for individual management, but also to inform the delivery of health promotion messages and health care.

【 授权许可】

   
2013 Sanna et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175-189.
• [2]Culpepper L: Generalized anxiety disorder and medical illness. J Clin Psychiatry 2009, 70:20-24.
• [3]Liew HP: Depression and chronic illness: a test of competing hypotheses. J Health Psychol 2012, 17:100-109.
• [4]Clarke DM, Currie KC: Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust 2009, 190:S54-S60.
• [5]Katon W, Lin E, Von Korff M, Russo J, Lipscomb P, Bush T: Somatization: a spectrum of severity. Am J Psychiatry 1991, 148:34-40.
• [6]Katon W, Ciechanowski P: Impact of major depression on chronic medical illness. J Psychosom Res 2002, 53:859-863.
• [7]Taylor D, Meader N, Bird V, Pilling S, Creed F, Goldberg D: Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry 2011, 198:179-188.
• [8]Gunn JM, Ayton DR, Densley K, Pallant JF, Chondros P, Herrman HE, Dowrick CF: The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol 2012, 47:175-184.
• [9]Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A: Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007, 22:613-626.
• [10]Goldston K, Baillie AJ: Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev 2008, 28:288-306.
• [11]Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, Marshall J, Minshall S, Robinson S, Fisher ML, Potenza M, Sigler B, Baldwin C, Thomas SA: The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004, 43:1542-1549.
• [12]Bogner HR, Cary MS, Bruce ML, Reynolds CF 3rd, Mulsant B, Ten Have T, Alexopoulos GS: The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study. Am J Geriatr Psychiatry 2005, 13:861-868.
• [13]Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31:2383-2390.
• [14]Lin EH, Korff MV, Alonso J, Angermeyer MC, Anthony J, Bromet E, Bruffaerts R, Gasquet I, de Girolamo G, Gureje O, Haro JM, Karam E, Lara C, Lee S, Levinson D, Ormel JH, Posada-Villa J, Scott K, Watanabe M, Williams D: Mental disorders among persons with diabetes–results from the World Mental Health Surveys. J Psychosom Res 2008, 65:571-580.
• [15]Pacini F, Calabrese C, Cipolletta L, Valva MD, Russo A, Savarino V, Vigneri S: Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin 2005, 21:495-502.
• [16]Covic T, Tyson G, Spencer D, Howe G: Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors. J Psychosom Res 2006, 60:469-476.
• [17]Hayes J, Koo J: Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther 2010, 23:174-180.
• [18]Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N: Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011, 12:160-174.
• [19]Lyness JM, Niculescu A, Tu X, Reynolds CF 3rd, Caine ED: The relationship of medical comorbidity and depression in older, primary care patients. Psychosomatics 2006, 47:435-439.
• [20]Zhang MW, Ho RC, Cheung MW, Fu E, Mak A: Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry 2011, 33:217-223.
• [21]Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J, Nader F, Younossi ZM: Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 2011, 52:127-132.
• [22]Hage MP, Azar ST: The link between thyroid function and depression. J Thyroid Res 2012, 2012:590648.
• [23]Patten SB, Williams JV, Lavorato DH, Modgill G, Jette N, Eliasziw M: Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry 2008, 30:407-413.
• [24]Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, Benjet C, Bromet E, de Girolamo G, de Graaf R, Gasquet I, Gureje O, Haro JM, He Y, Kessler RC, Levinson D, Mneimneh ZN, Oakley Browne MA, Posada-Villa J, Stein DJ, Takeshima T, Von Korff M: Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord 2007, 103:113-120.
• [25]Scott KM, McGee MA, Wells JE, Oakley Browne MA: Obesity and mental disorders in the adult general population. J Psychosom Res 2008, 64:97-105.
• [26]Onder G, Penninx BW, Cesari M, Bandinelli S, Lauretani F, Bartali B, Gori AM, Pahor M, Ferrucci L: Anemia is associated with depression in older adults: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2005, 60:1168-1172.
• [27]Guzman SJ, Nicassio PM: The contribution of negative and positive illness schemas to depression in patients with end-stage renal disease. J Behav Med 2003, 26:517-534.
• [28]Barsky AJ, Borus JF: Functional somatic syndromes. Ann Intern Med 1999, 130:910-921.
• [29]Gureje O, Simon GE, Von Korff M: A cross-national study of the course of persistent pain in primary care. Pain 2001, 92:195-200.
• [30]Fan AZ, Strine TW, Jiles R, Mokdad AH: Depression and anxiety associated with cardiovascular disease among persons aged 45 years and older in 38 states of the United States, 2006. Prev Med 2008, 46:445-450.
• [31]Yanovski SZ, Nelson JE, Dubbert BK, Spitzer RL: Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993, 150:1472-1479.
• [32]Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD: Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biol Psychiatry 2009, 66:91-93.
• [33]Lydiard RB: Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry 2001, 62:38-45. discussion 46–37
• [34]Harter MC, Conway KP, Merikangas KR: Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci 2003, 253:313-320.
• [35]Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH: Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord 2002, 69:209-217.
• [36]Katon W, Lin EH, Kroenke K: The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007, 29:147-155.
• [37]Cimpean D, Drake RE: Treating co-morbid chronic medical conditions and anxiety/depression. Epidemiol Psychiatr Sci 2011, 20:141-150.
• [38]DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
• [39]Strik JJ, Denollet J, Lousberg R, Honig A: Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003, 42:1801-1807.
• [40]Unutzer J, Schoenbaum M, Katon WJ, Fan MY, Pincus HA, Hogan D, Taylor J: Healthcare costs associated with depression in medically ill fee-for-service medicare participants. J Am Geriatr Soc 2009, 57:506-510.
• [41]Cohen S, Rodriquez MS: Pathways linking affective disturbances and physical disorders. Health Psychol 1995, 14:374-380.
• [42]Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R: Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002, 53:83-107.
• [43]Irwin M, Patterson T, Smith TL, Caldwell C, Brown SA, Gillin JC, Grant I: Reduction of immune function in life stress and depression. Biol Psychiatry 1990, 27:22-30.
• [44]Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008, 30:208-225.
• [45]Friedman B, Lyness JM, Delavan RL, Chunyu L, Barker WH: Major depression and disability in older primary care patients with heart failure. J Geriatr Psychiatry Neurol 2008, 21:111-122.
• [46]Berk M, Jacobson BF, Hurly E: Fluoxetine and hemostatic function: a pilot study. J Clin Psychiatry 1995, 56:14-16.
• [47]Williams LJ, Henry MJ, Berk M, Dodd S, Jacka FN, Kotowicz MA, Nicholson GC, Pasco JA: Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 2008, 23:84-87.
• [48]Almeida OP, Alfonso H, Hankey GJ, Flicker L: Depression, antidepressant use and mortality in later life: the Health In Men Study. PLoS One 2010, 5:e11266.
• [49]Katon WJ: Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 2011, 13:7-23.
• [50]Brenes GA: Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003, 65:963-970.
• [51]Pasco JA, Nicholson GC, Kotowicz MA: Cohort profile: Geelong Osteoporosis Study. Int J Epidemiol 2012, 41:1565-1575.
• [52]First M, Spitzer R, Gibbon M, Williams J: Structured Clinical Interview for DSM-IVTR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
• [53]Henry MJ, Pasco JA, Korn S, Gibson JE, Kotowicz MA, Nicholson GC: Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int 2010, 21:909-917.
• [54]World Health Organisation: Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. In WHO Technical Report Series 894. Geneva: WHO; 2000.
• [55]Giles C, Ireland P: Dietary Questionnaire for Epidemiological Studies (Version 2). Melbourne: The Cancer Council Victoria; 1996.
• [56]Australian Bureau of Statistics: Socio-Economic indices for Areas (SEIFA) - Technical Paper. Canberra ABS: Australian Bureau of Statistics; 2006.
• [57]Williams L, Jacka F, Pasco J, Henry M, Dodd S, Nicholson G, Kotowicz M, Berk M: The prevalence of mood and anxiety disorders in Australian women. Australas Psychiatry 2010, 18:250-255.
• [58]Brennan SL, Henry MJ, Wluka AE, Nicholson GC, Kotowicz MA, Pasco JA: Socioeconomic status and bone mineral density in a population-based sample of men. Bone 2010, 46:993-999.
• [59]Brennan SL, Henry MJ, Nicholson GC, Kotowicz MA, Pasco JA: Socioeconomic status, obesity and lifestyle in men: the Geelong Osteoporosis Study. J Men’s Health 2010, 7:31-41.
• [60]Haug TT, Mykletun A, Dahl AA: Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol 2002, 37:294-298.
• [61]Hu WH, Wong WM, Lam CL, Lam KF, Hui WM, Lai KC, Xia HX, Lam SK, Wong BC: Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002, 16:2081-2088.
• [62]Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, Lagergren J: Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 2007, 26:683-691.
• [63]Avidan B, Sonnenberg A, Giblovich H, Sontag SJ: Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 2001, 15:1907-1912.
• [64]Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27:193-210.
• [65]Williams LJ, Pasco JA, Jacka FN, Dodd S, Berk M: Pain and the relationship with mood and anxiety disorders and psychological symptoms. J Psychosom Res 2012, 72:452-456.
• [66]Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF: Migraine, quality of life, and depression: a population-based case–control study. Neurology 2000, 55:629-635.
• [67]Morgan H, Blashki G: Fits, faints and funny turns. Could it be a mental disorder? Aust Fam Physician 2003, 32:211-213. 216–219
• [68]Hoppe C, Elger CE: Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neurol 2011, 7:462-472.
• [69]Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G: Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 2003, 75:155-162.
• [70]De S: Prevalence of depression in stable chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2011, 53:35-39.
• [71]Williams LJ, Pasco JA, Jacka FN, Henry MJ, Dodd S, Berk M: Depression and bone metabolism. A review. Psychother Psychosom 2009, 78:16-25.
• [72]Mykletun A, Jacka F, Williams L, Pasco J, Henry M, Nicholson GC, Kotowicz MA, Berk M: Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterol 2010, 10:88.
• [73]Smith DF, Gerdes LU: Meta-analysis on anxiety and depression in adult celiac disease. Acta Psychiatr Scand 2012, 125:189-193.
• [74]Lopez-Colombo A, Morgan D, Bravo-Gonzalez D, Montiel-Jarquin A, Mendez-Martinez S, Schmulson M: The epidemiology of functional gastrointestinal disorders in Mexico: a population-based study. Gastroenterol Res Pract 2012, 2012:606174.
• [75]Irvine EJ: Quality of life assessment in gastro-oesophageal reflux disease. Gut 2004, 53:iv35-iv39.
• [76]Kroenke K, Price RK: Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993, 153:2474-2480.
• [77]Iosifescu DV, Nierenberg AA, Alpert JE, Smith M, Bitran S, Dording C, Fava M: The impact of medical comorbidity on acute treatment in major depressive disorder. Am J Psychiatry 2003, 160:2122-2127.
• [78]Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ: Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients’ self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996, 49:1407-1417.